Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

HLA-DRB1-DQA1-DQB1 genotype and frequency of enterovirus in longitudinal monthly fecal samples from healthy infants

E Witso, O Cinek, G Tapia, T Rasmussen, LC Stene, KS Ronningen

. 2012 ; 25 (3) : 187-192.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc17016703

Grantová podpora
NT11465 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje NLK Online Plný text

ProQuest Central od 2000-09-01 do 2018-12-31
Health & Medicine (ProQuest) od 2000-09-01 do 2018-12-31
Public Health Database (ProQuest) od 2000-09-01 do 2018-12-31

Enterovirus infections may be involved in the etiology of type 1 diabetes (T1D), which is strongly associated with certain human leukocyte antigen (HLA) class II haplotypes. Our aim was to assess whether HLA genotypes conferring varying degrees of risk for T1D were associated with enterovirus gut infections. From the general Norwegian population, 190 healthy infants at high-risk for T1D (DR4-DQ8/DR3-DQ2), and 383 infants without this genotype were identified. Non-DR4-DQ8/DR3-DQ2 genotypes were further categorized as conferring either an increased-to-moderate risk (DR4-DQ8 or DR3-DQ2), were protective (DQB1*06:02), or were neutral (all other genotypes). A total of 4626 monthly fecal samples taken between age 3 and 12mo were tested for enterovirus RNA using real-time PCR. Enterovirus prevalence was 11.5% among high-risk children, and 12.2% in other children (adjusted odds ratio: 1.23, p=0.12). The prevalence was 11.3% in those with increased-to-moderate risk, 13.0% in the protective group, and 12.6% in the neutral group (likelihood ratio test, 3 d.f.: p=0.37). In conclusion, there was no statistically significant association between HLA genotype and the occurrence of human enterovirus gut infections.

000      
00000naa a2200000 a 4500
001      
bmc17016703
003      
CZ-PrNML
005      
20170516112136.0
007      
ta
008      
170516s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/vim.2012.0001 $2 doi
035    __
$a (PubMed)22691100
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Witso, Elisabet $u Witso, Elisabet. Norwegian Institute of Public Health, Postboks 4404 Nydalen, 0403 Oslo, Norway. elisabet.witso@fhi.no
245    10
$a HLA-DRB1-DQA1-DQB1 genotype and frequency of enterovirus in longitudinal monthly fecal samples from healthy infants / $c E Witso, O Cinek, G Tapia, T Rasmussen, LC Stene, KS Ronningen
520    9_
$a Enterovirus infections may be involved in the etiology of type 1 diabetes (T1D), which is strongly associated with certain human leukocyte antigen (HLA) class II haplotypes. Our aim was to assess whether HLA genotypes conferring varying degrees of risk for T1D were associated with enterovirus gut infections. From the general Norwegian population, 190 healthy infants at high-risk for T1D (DR4-DQ8/DR3-DQ2), and 383 infants without this genotype were identified. Non-DR4-DQ8/DR3-DQ2 genotypes were further categorized as conferring either an increased-to-moderate risk (DR4-DQ8 or DR3-DQ2), were protective (DQB1*06:02), or were neutral (all other genotypes). A total of 4626 monthly fecal samples taken between age 3 and 12mo were tested for enterovirus RNA using real-time PCR. Enterovirus prevalence was 11.5% among high-risk children, and 12.2% in other children (adjusted odds ratio: 1.23, p=0.12). The prevalence was 11.3% in those with increased-to-moderate risk, 13.0% in the protective group, and 12.6% in the neutral group (likelihood ratio test, 3 d.f.: p=0.37). In conclusion, there was no statistically significant association between HLA genotype and the occurrence of human enterovirus gut infections.
590    __
$a bohemika - dle Pubmed
650    02
$a diabetes mellitus 1. typu $x genetika $x virologie $7 D003922
650    02
$a Enterovirus $x genetika $x izolace a purifikace $7 D004770
650    12
$a enterovirové infekce $7 D004769
650    12
$a feces $x virologie $7 D005243
650    02
$a ženské pohlaví $7 D005260
650    02
$a genetická predispozice k nemoci $7 D020022
650    02
$a genotyp $7 D005838
650    12
$a HLA-DQ alfa řetězec $x genetika $7 D059848
650    12
$a HLA-DQ beta řetězec $x genetika $7 D059866
650    12
$a HLA-DRB1 řetězec $x genetika $7 D059811
650    02
$a testování histokompatibility $7 D006650
650    02
$a lidé $7 D006801
650    02
$a kojenec $7 D007223
650    02
$a mužské pohlaví $7 D008297
700    1_
$a Cinek, Ondřej, $d 1972- $7 nlk20050167617
700    1_
$a Tapia, German
700    1_
$a Rasmussen, Trond
700    1_
$a Stene, Lars C.
700    1_
$a Ronningen, Kjersti S.
773    0_
$t Viral Immunology $g Roč. 25, č. 3 (2012), s. 187-192 $p Viral Immunol $x 0882-8245 $w MED00004658
773    0_
$p Viral Immunol $g 25(3):187-92, 2012 Jun
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20170516112522 $b ABA008
991    __
$a 20170516112522 $b ABA008
999    __
$a ok $b bmc $g 1205152 $s 977512
BAS    __
$a 3
BMC    __
$a 2012 $b 25 $c 3 $d 187-192 $x MED00004658 $i 0882-8245 $m Viral immunology
GRA    __
$a NT11465 $p MZ0
LZP    __
$a NLK 2015-B/lp

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...